English   español  

Browsing by Author Orlowski, R. Z.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2017A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myelomaLaubach, Jacob P.; Moslehi, Javid J.; Francis, Sanjeev A.; San Miguel, Jesús F. ; Sonneveld, Pieter; Orlowski, R. Z.; Moreau, Philippe; Rosiñol, Laura; Faber Jr., Edward A.; Voorhees, Peter; Mateos, Maria Victoria; Marquez, Loreta; Feng, Huaibao; Desai, Avinash; Velde, Helgi van de; Elliott, Jennifer; Shi, Hongliang; Dow, Edward; Jobanputra, Nishith; Esseltine, Dixie-Lee; Niculescu, Liviu; Anderson, Kenneth; Lonial, Sagar; Richardson, Paul G.artículo
openAccesselotustud.pdf.jpg2020Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 studyDimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Weisel, Katja C.; San-Miguel, Jesús; Shpilberg, Ofer; Grosicki, Sebastian; Špička, Ivan; Walter-Croneck, Adam; Magen, Hila; Mateos, Maria Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Spencer, Andrew; Oakervee, Heather; Orlowski, R. Z.; Taniwaki, Masafumi; Röllig, Christoph; Einsele, Hermann; Matsumoto, Morio; Wu, Ka Lung; Anderson, Kenneth; Jou, Ying-Ming; Ganetsky, Alex; Singhal, Anil K.; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2014New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)Ocio, Enrique M.  ; Richardson, Paul G.; Rajkumar, S. Vincent; Palumbo, Antonio; Mateos, Maria Victoria; Orlowski, R. Z.; Kumar, S. ; Dimopoulos, Meletios A.; Merlini, Giampolo; Lahuerta, Juan José; Lonial, Sagar; Moreau, Philippe; Ludwig, Heinz; San Miguel, Jesús F. artículo
closedAccessaccesoRestringido.pdf.jpg2019Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 studyMateos, Maria Victoria; Orlowski, R. Z.; Ocio, Enrique M.  ; Rodríguez-Otero, Paula; Reece, Donna; Moreau, Philippe; Munshi, Nikhil; Avigan, David E.; Siegel, David S.; Ghori, Razi; Farooqui, Mohammed Z. H.; Marinello, Patricia; San Miguel, Jesús F. artículo
openAccessPlasma cell leukemia.pdf.jpg2013Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working GroupFernández de Larrea, Carlos; San Miguel, Jesús F. ; Palumbo, Antonio; Dimopoulos, Meletios A.; Chanan-Khan, Asher A.; Moreau, Philippe; Merlini, Giampolo; Lahuerta, Juan José; Bladé, Joan; Orlowski, R. Z.artículo
closedAccessaccesoRestringido.pdf.jpg2012Proteasome inhibitors in multiple myeloma: 10 years laterMoreau, Philippe; Richardson, Paul G.; Cavo, Michele; Orlowski, R. Z.; San Miguel, Jesús F. ; Palumbo, Antonio; Harousseau, Jean-Lucartículo